Followers | 71 |
Posts | 3485 |
Boards Moderated | 0 |
Alias Born | 04/08/2022 |

Friday, January 03, 2025 11:44:13 AM
Recent ELAB News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 12:00:27 PM
- Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • InvestorsHub NewsWire • 03/10/2025 01:05:43 PM
- Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • GlobeNewswire Inc. • 03/10/2025 12:00:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/06/2025 02:06:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 02:01:00 PM
- PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance • GlobeNewswire Inc. • 03/06/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2025 10:08:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 09:01:20 PM
- PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group • GlobeNewswire Inc. • 02/27/2025 01:00:00 PM
- PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market • GlobeNewswire Inc. • 02/26/2025 01:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/24/2025 09:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 09:01:25 PM
- Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Rec • GlobeNewswire Inc. • 02/18/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 04:14:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 09:01:40 PM
- Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1 • GlobeNewswire Inc. • 02/04/2025 01:00:32 PM
- PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies • GlobeNewswire Inc. • 01/31/2025 03:33:22 PM
- Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • GlobeNewswire Inc. • 01/30/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 09:01:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2025 09:37:31 PM
- PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors • GlobeNewswire Inc. • 01/27/2025 02:00:36 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/27/2025 11:03:57 AM
- Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium • GlobeNewswire Inc. • 01/24/2025 01:00:00 PM
FEATURED 4Cable TV International, Inc. Unleashes Bold Strategy to Maximize Shareholder Value with close to 7.8 billion Dilutive Shares Eliminated • Mar 18, 2025 1:15 PM
FEATURED Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • Mar 18, 2025 8:36 AM
FEATURED Xtreme One Entertainment Announces $1.5 Million Private Placement • Mar 18, 2025 12:00 AM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM